A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Advances in HIV and AIDS Control
Currently, 17 million people worldwide are receiving antiretroviral therapy (ART) for human immunodeficiency viral (HIV) infection. There has been a dramatic decline in mortality from HIV infection in the last decade due to increased availability of ART. HIVassociated cardiac failure is on the increase, with more cases of diastolic dysfunction reported in the ART era. HIV increases the risk of CVD, because of longer survival on ART, ongoing subclinical inflammation, traditional cardiovasculardoi:10.5772/intechopen.80483 fatcat:g2pluynzonhfzlaky6bji5onc4